![James G. Barsoum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
James G.
Barsoum worked as the Director of Molecular & Cellular Biology at Biogen MA, Inc. from 1987 to 2003.
He then worked as the Senior Vice President of Research at Synta Pharmaceuticals Corp.
from 2003 to 2009.
After that, he served as the Chief Scientific Officer at Translate Bio, Inc. and Theracrine, Inc. respectively.
Barsoum earned a doctorate degree from the Massachusetts Institute of Technology.
Former positions of James G. Barsoum
| Companies | Position | End |
|---|---|---|
| TRANSLATE BIO, INC. | Chief Tech/Sci/R&D Officer | 12/09/2016 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Chief Tech/Sci/R&D Officer | 30/10/2009 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Corporate Officer/Principal | 01/02/2003 |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Chief Tech/Sci/R&D Officer | - |
Training of James G. Barsoum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Theracrine, Inc.
Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- James G. Barsoum
